Professional Documents
Culture Documents
Discitis and Spinal Infection: Classi Fication and Epidemiology
Discitis and Spinal Infection: Classi Fication and Epidemiology
Discitis and spinal involves a pus-producing infection of the disc and vertebrae. It can
be considered that spondylitis, discitis and spondylodiscitis are a
continuum of the same process.1 This clinical spectrum can also
infection involve primary or more commonly secondary epidural abscess,
pyogenic facet joint septic arthritis and vertebral osteomyelitis.
Edward Matthews
Oliver Stokes Classification and epidemiology
Spinal infection can be characterized by the immune reaction to
the causative organism. In the developed world the majority
Abstract cause a pyogenic reaction. The developing world has a higher
Spinal infection poses a diagnostic challenge and a low threshold for burden of disease from Mycobacterium tuberculosis (TB) and
investigation should be maintained. Presentation is varied and non- zoonotic infections.
specific symptoms mean that patients are investigated by many spe- Meticillin sensitive Staphylococcus aureus (MSSA) is the
cialities. The majority of spinal infection is from haematogenous most common organism isolated (63%) and along with
spread and therefore an origin of infection needs to be sought. Treat- Streptococcus species (20%)1 cause the majority of infections.
ment of spondylodiscitis is routinely managed by non-surgical treat- However, in 25e33% of patients no pathogen is isolated.1,2 Other
ment with a prolonged period of antibiotics. Complications of typical organisms include Gram negative bacilli, commonly seen
spondylodiscitis can lead to morbidity and may be difficult to treat in infections secondary to intravenous drug abuse. Salmonella
and often require surgery. It is essential to attempt to obtain microbi- infection is more common in those patients with immune
ological diagnosis. Initial management and investigation does affect compromise and sickle cell anaemia.2 Table 1 provides a list of
treatment strategies and it is important to understand this. commonly encountered pathogens and their prevalence.
Keywords Discitis; epidural abscess; osteomyelitis; spinal infection; Granulomatous discitis occurs most commonly from M.
spondylodiscitis; vertebral tuberculosis (TB) and brucellosis. These combined with Candida
spp. and other fungal infections cause significant morbidity and
mortality in the immunosuppressed and in the developing world.
Introduction Brucella infection, a zoonosis, occurs secondary to consuming
unpasteurized dairy products or occupational exposure to
Adult spinal infection is an uncommon clinical condition and has
infected animals.
the potential to cause a spectrum of morbidity and occasionally
Spondylodiscitis accounts for a small burden of disease in the
mortality. This article provides the reader with an understanding
developed healthcare system and has been reported to represent
of spinal infection and an update on current guidelines and
2e7% of all cases of osteomyelitis.2 The burden of spondylo-
evidence-based best practice.
discitis is reported to have an incidence of 3.7/100,000 per year
Spinal infections can range from indolent to rapidly indolent
according to recent UK-based study.3
or rapidly destructive. Immunocompromised patients are
Factors that increase this risk of developing discitis in the UK
particularly at risk, and spinal infections can present to a wide
are widely reported to be diabetes mellitus, steroid use and
range of surgical and medical specialities. The natural history of
immunosuppression, intravenous drug abuse, malnutrition and
the disease is dependent on host, pathogen and comorbid vari-
renal failure. These are summarized in Box 1. Tuberculosis and
ables and can lead to progressive destruction which if untreated
human immunodeficiency virus (HIV) pose a significant burden
can result in significant deformity, neural compromise and death.
of disease in the developing world. Pyogenic spondylitis is more
The clinical picture on presentation or diagnosis affects subse-
common in the elderly, whereas epidural abscess is more of a
quent investigation and management. Therefore, thorough
problem with disseminated bacteraemia and iatrogenic causes.
assessment of these patients is essential. Spinal infections most
Hadjipavlou et al.1 found septicaemia to be the biggest risk factor
often occur due to haematogenous spread of infection from
for spondylodiscitis, with tobacco and intravenous drug use
elsewhere in the body; de novo spinal infection is rare, therefore
being the next most common risk factor (Table 1 and Box 1).
multisystem assessment of these patients is important.
There are a number of descriptive medical names that are
Pathogenesis
synonymous for the same clinical entity. Discitis refers to an
infective condition of the intervertebral disc. Commonly this is The aetiology of spinal infection is either haematogenous spread,
used to describe pyogenic spondylodiscitis, taking the prefix from iatrogenic or contiguous. Haematogenous infection can be
the Greek, spondylos, for vertebra, a clinical condition that disseminated by either the arterial tree or the venous system.
This is the most commonly encountered source in clinical prac-
tice. The arterial vascular supply to the spine is via segmental
arteries. The intervertebral disc itself is avascular (in adults). The
Edward Matthews FRCS(Tr & Orth) is a Trauma and Orthopaedic vertebral endplate, however, is vascularized, allowing for direct
Specialist Registrar in the South West Deanery, UK. Conflicts of extension from endplate to disc, hence the surrounding end
interest: none. plates are involved in cases of discitis, leading to the term
Oliver Stokes FRCS (Tr & Orth) MSc is a Consultant Spinal Surgeon at spondylodiscitis the term spondylodiscitis is often used. Prostatic
the Royal Devon and Exeter Hospital, Exeter, UK. Conflicts of biopsy can lead to a venous source of infection via the valveless
interest: none. vertebral veins of Batson. Infective endocarditis and urinary tract
Plain radiographs are not useful in the acute diagnostic work Bracing
up; it is widely accepted that there is a period of 4 weeks in which Orthotic use in spinal infection has a limited evidence base.
radiographic signs will not be present in spondylodiscitis, if at Where the presence of infection leads to deformity and spinal
all. The common findings are a destructive process that is centred instability the use of an orthotic is likely to be insufficient apart
around the disc space, i.e. the superior endplate and the inferior from a temporary device to give comfort, and not as a long-term
end of the vertebral body above. Due to a destructive appear- solution. Surgery for kyphosis and pseudarthrosis provides a
ance, it is also important to rule out a neoplastic process and a better outcomes and lower pain scores.1
myeloma screen including serum electrophoresis and urinary
Bence-Jones proteins to diagnose myeloma should be performed. Surveillance
It is important to consider the aetiology of discitis when a Patients should be reviewed regularly to evaluate clinical
diagnosis is established. Careful evaluation of risk factors could improvement in pain and systemic symptoms. Clinical exami-
point to infective endocarditis, intravenous catheter infection, nation should also be regularly repeated to assess for neurolog-
solid organ abscess and haemodialysis, all of which have sig- ical sequelae and development of deformity. The use of serial
nificant morbidity and mortality if not recognized and treated. inflammatory markers is widely reported but there is limited
evidence on to how to interpret slowly declining CRP. It has been
Management reported that a CRP of 27.5 mg/l at 4 weeks could be a predictive
marker of how effective treatment is but there is a paucity of
The management can be complex and needs tailoring to the evidence for this.6
patient’s clinical picture.
Outcomes
Antibiotics
The mainstay of treatment is a course of intravenous antibiotics If patients suffer from a complication of discitis they have a poorer
until inflammatory markers are on a downward trend and outcome. The potential for paralysis and deformity pose signifi-
heading towards a C-reactive protein (CRP) below 50 mg/l. cant morbidity. Absolute failure can cause, at best, deformity and
CRP of less than 30 mg/l is common around the 4-week point, pain with ongoing osteomyelitis and, at worst, it can cause death
following treatment, according to Sur et al.3 There is also no from sepsis. Figure 2 demonstrates an inadequately treated spinal
consensus on the length of intravenous therapy and on the infection in a patient showing significant destruction and
conversion to oral therapy. There is evidence that 6 weeks of deformity.
antibiotic therapy has no inferiority to 3 months of antibiotics.12 Epidural abscess formation secondary to discitis is a common
The current consensus on empirical antibiotic therapy is that complication of infection, affecting 35% in one series,1 and one-
there should be careful evaluation of patient background, past third these cases were associated with paralysis.
medical history and social and geographic susceptibility.8 Where Mortality from discitis is rare. A recent case series from
fungal or mycobacterial pathogens are suspected there is a Madrid reported a mortality of 7/108 (6.5%).14 The 1-year
limited role for empirical therapy. mortality has been reported to be 11%,15 but attributing this
The main pyogenic organisms are MSSA, meticillin resistant mortality rate solely to discitis is difficult due to the underlying
S. aureus (MRSA) and streptococcal species and Gram negative comorbidities present in many affected patients. Comorbid pa-
species; local empiric guidance will involve broad-spectrum an- tients represent the more likely to be affected and they are likely
tibiotics until culture positive guidance agent can be employed. to have the worst outcomes.
4 Skaf GS, Domloj NT, Fehlings MG, et al. Pyogenic spondylo- 10 Jha AASIA. Impairment scale. In: Encyclopedia of clinical neuro-
discitis: an overview. J Infect Public Health 2010; 3: 5e16. King psychology. New York, NY: Springer, 2011; 255e7.
Saud Bin Abdulaziz University for Health Sciences. 11 Hong SH, Choi J-Y, Lee JW, Kim NR, Choi J-A, Kang HS. MR
5 Bhavan KP, Marschall J, Olsen MA, Fraser VJ, Wright NM, imaging assessment of the spine: infection or an imitation? Ra-
Warren DK. The epidemiology of hematogenous vertebral osteo- dioGraphics. Radiol Soc North Am 2009 Mar; 29: 599e612.
myelitis: a cohort study in a tertiary care hospital. BMC Infect Dis 12 Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks
2010 Jun 7; 10: 198. BioMed Central. versus 12 weeks in patients with pyogenic vertebral osteomyelitis:
6 Yoon SH, Chung SK, Kim K-J, Kim H-J, Jin YJ, Kim HB. Pyogenic an open-label, non-inferiority, randomised, controlled trial. Lancet
vertebral osteomyelitis: identification of microorganism and lab- 2015; 385: 875e82.
oratory markers used to predict clinical outcome. Eur Spine J 13 Do Kim S, Melikian R, Ju KL, et al. Independent predictors of
2009 Nov 24; 19: 575e82. failure of nonoperative management of spinal epidural abscesses.
7 Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on Spine J 2014 Aug 1; 14: 1673e9. Elsevier Inc.
diagnosis and management. J Antimicrob Chemother 2010 Sep 14 Cebrian Parra JL, Saez-Arenillas Martín A, Urda Martínez-
28; 65(suppl 3): iii11e24. Aedo AL, Soler Ivan~ez I, Agreda E, Lopez-Duran Stern L. Man-
8 Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases agement of infectious discitis. Outcome in one hundred and eight
Society of America (IDSA) clinical practice guidelines for the patients in a University Hospital. Int Orthop (SICOT) 2012 Jan 4;
diagnosis and treatment of native vertebral osteomyelitis in adults, 36: 239e44. Springer-Verlag.
vol. 61. Clinical Infectious Diseases : an Official Publication of the 15 Kehrer M, Pedersen C, Gorm Jensen T, Hallas J, Lassen AT.
Infectious Diseases Society of America, 2015; e26e46. Increased short- and long-term mortality among patients with
9 Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical vs nonoper- infectious spondylodiscitis compared with a reference population.
ative treatment for lumbar disk herniation: the Spine Patient Spine J 2015 Jun 1; 15: 1233e40. Elsevier Inc.
Outcomes Research Trial (SPORT): a randomized trial. JAMA,
J Am Med Assoc 2006 Nov 22; 296: 2441e50.